Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BrightSpring Health Services, Inc. (BTSG)
NASDAQ:BTSG
RESEARCH TOOLSreports
Holding BTSG?
Track your performance easily
See the Price Targets and Ratings of:
BTSG Analyst Ratings
Strong Buy
9 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BTSG Stock 12 Month Forecast
Average Price Target
$19.94
▲(6.63% Upside)
| Highest Price Target$23.00 | Average Price Target$19.94 | Lowest Price Target$17.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Reiterated
11/04/24
Deutsche Bank
Reiterated
11/04/24
Leerink Partners
Reiterated
11/04/24
Mizuho Securities
Reiterated
11/03/24
BTIG
Reiterated
11/01/24
Guggenheim
Reiterated
10/01/24
Wells Fargo
Reiterated
09/16/24
Jefferies
Reiterated
09/10/24
Bank of America Securities
Reiterated
05/15/24
HSBC
$13
Buy
-30.48%
Downside
Initiated
03/06/24
BrightSpring Health initiated with a Buy at HSBCBrightSpring Health initiated with a Buy at HSBC
Goldman Sachs
$26
Buy
39.04%
Upside
Reiterated
02/29/24
We are Buy Rated. 2024 Guide - Revenue guidance of $9,350 - 9,500 was largely in-line with our $9,431M estimate and implied growth of 5.9-7 .6% excluding future M&A. EBITDA guidance of $550 - 564M captured our EBITDA estimate (ex-M&A) of $563M. The company noted that EBITDA guidance excludes contribution from quality incentive payments, of which we include approximately $16M in our 2024 EBITDA estimates. On an underlying basis, EBITDA guidance in particular looks better than expected to us. 4Q Performance - Revenue and EBITDA were both in-line to slightly ahead of expectations. 4Q revenue of $2,375M was ahead of our estimate of $2,364M by roughly 50bps, while EBITDA of $143M was ahead of our $142M estimate. Cash flow from operations of $162M was also materially stronger than our $45M estimate, and drove full-year FCF of $137M.
―
KeyBanc
―
Hold
―
Assigned
11/04/24
Best Analysts Covering BrightSpring Health Services, Inc.
Which Analyst Should I Follow If I Want to Buy BTSG and Sell After:
1 Month
xxx
Success Rate
3/3 ratings generated profit
Average Return
+11.93%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +11.93% per trade.
3 Months
xxx
Success Rate
3/3 ratings generated profit
Average Return
+29.50%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +29.50% per trade.
1 Year
Success Rate
6/6 ratings generated profit
Average Return
+70.73%
reiterated a buy rating 2 months ago
Copying Steve Baxter's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +70.73% per trade.
2 Years
xxx
Success Rate
6/6 ratings generated profit
Average Return
+70.73%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +70.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BTSG Analyst Recommendation Trends
Rating
Jun 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
4
3
3
2
0
Buy
8
11
8
8
9
Hold
0
0
0
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
14
11
11
11
Each month's total comprises the sum of three months' worth of ratings.
BTSG Financial Forecast
BTSG Stock Forecast FAQ
What is BTSG’s average 12-month price target, according to analysts?
Based on analyst ratings, BrightSpring Health Services, Inc.’s 12-month average price target is $19.94.
What is BTSG’s upside potential, based on the analysts’ average price target?
BrightSpring Health Services, Inc. has 6.63% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BTSG a Buy, Sell or Hold?
BrightSpring Health Services, Inc. has a consensus rating of Strong Buy which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
What is BrightSpring Health Services, Inc.’s price target?
The average price target for BrightSpring Health Services, Inc. is $19.94. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $23.00 ,the lowest forecast is $17.00. The average price target represents 6.63% Increase from the current price of $18.7.
The highest analyst price target is $23.00 ,the lowest forecast is $17.00. The average price target represents 6.63% Increase from the current price of $18.7.
What do analysts say about BrightSpring Health Services, Inc.?
BrightSpring Health Services, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of BTSG?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.